Natera

Following last week's announcement that Illumina had acquired Verinata Health in a deal worth up to $450 million, other companies that use Illumina's technology for their own noninvasive prenatal tests said the acquisition, though unexpected, ultimately validates the field.

Since Sequenom launched the first noninvasive prenatal sequencing test for Down syndrome and other fetal aneuploidies in October 2011, the field has exploded.

NEW YORK (GenomeWeb News) – National managed healthcare company WellPoint has revised its medical policy regarding non-invasive fetal aneuploidy screening, suggesting that it will begin covering tests such as Sequenom's MaterniT21 Plus test.

Citing the success of non-invasive sequencing-based prenatal tests for fetal aneuploidies, several researchers at last week's American Society of Human Genetics conference in San Francisco reported that they are looking to expand the technique to screen for other genetic disorder

This article has been updated to clarify the turnaround time for Natera's test. It is two weeks.

NEW YORK (GenomeWeb News) – With the arrival over the past year of several new prenatal genetic diagnostic tests and recent advances in sequencing the fetal genome, genomic medicine has begun to show how it may be used to diagnose diseases in fetuses early in pregnancy and with high accuracy, but

This story has been revised to clarify the tests' different no-call rates.

Dennis Lo's team at the Chinese University of Hong Kong, which pioneered a shotgun sequencing approach to noninvasively detect fetal aneuploidies from maternal plasma, has tested a new targeted sequencing approach to detect trisomy but has found it inferior to the previous method

Researchers from Radboud University Nijmegen Medical Center have published a method of non-invasive prenatal diagnosis using massively parallel sequencing-by-ligation on the Life Technologies SOLiD 4 platform.

Pages

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.